Agilent Receives a Buy from BTIG

By George MacDonald

BTIG analyst Dane Leone reiterated a Buy rating on Agilent (NYSE: A) yesterday and set a price target of $52. The company’s shares opened today at $41.79.

Currently, the analyst consensus on Agilent is Moderate Buy and the average price target is $50, representing a 19.6% upside. In a report released today, Jefferies also reiterated a Buy rating on the stock with a $48 price target.

Agilent`s market cap is currently $14.02B and has a P/E ratio of 37.1. The company has a book value ratio of 3.31%.

Financial bloggers on sites such as wsobserver.com, zacks.com and others, seem to have Positive view on A. When evaluating the opinions of financial bloggers over the last 3 months, 75% of bloggers have indicated a Bullish sentiment, while 25% have indicated a Bearish sentiment. The average blogger Bullish sentiment in the sector is 68% which is less positive than the blogger sentiment of A.

Unlike BTIG`s latest rating, based on the recent corporate insider activity of 67 insiders, corporate insider sentiment is neutral on the stock. Most recently, in March 2015, Barry Rand, a Director at A sold 8,870 shares for a total of $363,227.

According to TipRanks.com, Leone is a 4-star analyst with an average return of 10.4% and a 77.1% success rate. Leone covers the Healthcare sector, focusing on stocks such as Quest Diagnostics Inc., NanoString Tech, and Thermo Fisher.

Agilent Technologies Inc provides core bio-analytical and electronic measurement solutions to the life sciences, diagnostics and genomics, chemical analysis, communications and electronics industries.